CD9 and acute myeloid leukemia: As shown in Figure 6, the expression of MRD1 and MRP1 were increased by 2.4- and 3.8-fold changes in the presence of 30 μg new case AML-EVs and relapsed AML-EVs, respectively (P < .01, P < .001).